Noguchi Memorial Institute of Medical Research, University of Ghana, Legon, Ghana.
Public Health and Reference Laboratory, Ghana Health Service, Accra, Ghana.
Hum Vaccin Immunother. 2021 Jul 3;17(7):2117-2124. doi: 10.1080/21645515.2020.1852009. Epub 2021 Jan 30.
On August 25, 2019, the Noguchi Memorial Institute for Medical Research notified the confirmation of a circulating-vaccine-derived poliovirus type-2 (cVDPV2) from the Agbogbloshie environmental surveillance (AES) site, in the Greater Accra Region. A field investigation of the outbreak was conducted to describe the results of epidemiological and laboratory investigations, and control efforts.
We conducted a descriptive investigation, records review, and active-case-search. Caregivers were interviewed on the vaccination status of their children; knowledge, attitude, and practices on polio prevention; water, sanitation and hygiene practices, and health-seeking behaviors. Stool from healthy children <5 y and sewage samples were taken for laboratory diagnosis.
cVDPV2 genetically similar to the cVDPV2 diagnosed recently in the Northern Region of Ghana and Nigeria was identified. 2019 half-year coverage of OPV and IPV was 22%. Fully immunized children were 49% (29/59). Most health workers (70%) had a fair knowledge of polio and acute flaccid paralysis (AFP). Forty-six percent of care-givers admitted to using the large drain linked to the site where the cVDPV2 was isolated as their place of convenience and disposing of the fecal matter of their children. No AFP case was identified. Stool samples from 40 healthy children yielded non-polio enteroviruses while 75% (3/4) of the additional sewage samples yielded cVDPV2.
cVDPV2 was isolated from the AES site. No AFP or poliovirus was identified from healthy children. There is a need to improve health workers' knowledge on AFP and to address the dire sanitation conditions in the Agbogbloshie market and its environs.
2019 年 8 月 25 日,恩戈基纪念医学研究所通知确认在大阿克拉地区阿格博格布洛西环境监测点(AES)发现循环疫苗衍生脊髓灰质炎 2 型病毒(cVDPV2)。开展了疫情现场调查,以描述流行病学和实验室调查以及控制工作的结果。
我们开展了描述性调查、记录回顾和主动病例搜索。对儿童的疫苗接种情况、对脊髓灰质炎预防的知识、态度和做法、水、环境卫生和卫生行为等方面对照顾者进行了访谈。采集了<5 岁健康儿童的粪便和污水样本进行实验室诊断。
发现了与最近在加纳北部地区和尼日利亚诊断出的 cVDPV2 基因相似的 cVDPV2。2019 年上半年 OPV 和 IPV 的覆盖率为 22%。完全免疫的儿童为 49%(29/59)。大多数卫生工作者(70%)对脊髓灰质炎和急性弛缓性麻痹(AFP)有一定的了解。46%的照顾者承认使用与发现 cVDPV2 的地点相连的大型排水沟作为方便之处,并处理他们孩子的粪便。没有发现 AFP 病例。从 40 名健康儿童的粪便样本中分离出非脊髓灰质炎肠道病毒,而 75%(3/4)的其他污水样本中分离出 cVDPV2。
从 AES 地点分离出 cVDPV2。从健康儿童中未发现 AFP 或脊髓灰质炎病毒。有必要提高卫生工作者对 AFP 的认识,并解决阿格博格布洛西市场及其周边地区严峻的卫生条件。